title: The patentability of antibodies in the United States.
abstract: Recent US case law attempts to further clarify the written description, novelty and non-obviousness requirements as they apply to antibodies
authors.affiliation: Frommer Lawrence & Haug LLP, 745 Fifth Avenue, New York, New York 10151, USA.
authors.forename: Deborah L
authors.initials: DL
authors.lastname: Lu
authors.forename: Angela M
authors.initials: AM
authors.lastname: Collison
authors.forename: Thomas J
authors.initials: TJ
authors.lastname: Kowalski
mesh_terms: D000906:Antibodies / Q000737:chemistry*; D001709:Biotechnology / Q000331:legislation & jurisprudence* / Q000639:trends*; D004345:Drug Industry / Q000331:legislation & jurisprudence* / Q000639:trends*; D033161:Government Regulation; D010330:Patents as Topic; D014481:United States
chemical_list: D000906:Antibodies